<!--START from /var/www/html/php4/ydp_trunk/local/templates/ydpprotocol/protocol_form_template.html comment made with MMCM-->
{clni_form}
<h3>Congestive Heart Failure</h3>
1. Key elements of the history/physical that are treatment targets for Congestive Heart Failure?<br>
{input style="width: 6in; height: 1in;" name="history_targets" type="text" size="50"
value="Years of known congestive heart failure, treatment history, smoking history, obesity, Blood pressure, BMI.
"}<br>

2. What are the patients Risk Factors that are treatment targets for Congestive Heart Failure?<br>
{input style="width: 6in; height: 1in;" name="risk_factors" type="text" size="50" 
value="Family history, obesity, hypertension, lipid elevation,protocols not indicated or contraindicated, patient declined, economic, social, religious, resource unavailable, insurance limitations, other
"}<br>

3. What are the Treatment Goals for Congestive Heart Failure?<br>
{input style="width: 6in; height: 1in;" name="treatment_goals" type="text" size="50" 
value="Decreased shortness of breath, decreased edema, increased exercise tolerance.
"}<br>

4. What are the typical Medications for Congestive Heart Failure?<br>
{input style="width: 6in; height: 1in;" name="medications" type="text" size="50" 
value="Diuretics and salt restriction in patients with current or prior symptoms of heart failure and reduced left ventricular ejection fraction who have evidence of fluid retention
.Aspirin
.Angiotensin converting enzyme (ACE) inhibitors
.Beta-adrenergic blockers
.Angiotensin receptor blockers (ARBs)
.Digoxin
.Aldosterone antagonists, such as spironolactone and eplerenone
.Hydralazine and a nitrate
.Infusion of a positive inotropic drug only as palliation for patients with end-stage disease
.Warfarin for paroxysmal or chronic atrial fibrillation

"}<br>

5. Indications for lab studies for Congestive Heart Failure?<br>
{input style="width: 6in; height: 1in;" name="lab_studies" type="text" size="50" 
value="Complete blood count, urinalysis, serum electrolytes (including calcium and magnesium), blood urea nitrogen, serum creatinine, fasting blood glucose, lipid profile, liver function tests, and thyroid-stimulating hormone, Screening for hemochromatosis, sleep-disturbed breathing, or human immunodeficiency virus, in selected patients, rheumatologic diseases, amyloidosis, or pheochromocytoma, if indicated, Endomyocardial biopsy, when specific diagnosis is suspected that would influence therapy

"}<br>

6. Indications for imaging studies for Congestive Heart Failure?<br>
{input style="width: 6in; height: 1in;" name="imaging_studies" type="text" size="50" 
value="Baseline EKG, CXR- PA/ Lateral, Two-dimensional echocardiogram coupled with Doppler flow studies,  Coronary arteriography in appropriate patients, Maximal exercise testing with or without measurement of respiratory gas exchange and/or blood oxygen saturation in appropriate patients, Holter monitoring, if indicated

"}<br>

7. Outcome goals for Congestive Heart Failure?<br>
{input style="width: 6in; height: 1in;" name="followup" type="text" size="50"
value="Key indicators:
.Percentage of patients with HF who have quantitative or qualitative results of LVF
.Percentage of patients who have EF recorded if hospitalized
.Percentage of patients with weight measurement recorded
.Percentage of patient visits with blood pressure recorded
.Percentage of patients with education during one or more visits during year
.Percentage of patients on Beta blocker with LVSD
.Percentage of patients on ACEI with LVSD
.Percantage of patients with sudden or chronic atrial fibrillation on warfarin therapy
.YDP additional standards
.Patient understanding of disease, satisfaction with care
.Percentage goals met per risk factor adjusted diagnosis
.Percentage of patients weight weighed and counselled on weight, exercise
"}<br>

8. Referral criteria, if referring patient out for Congestive Heart Failure?<br>
{input style="width: 6in; height: 1in;" name="followup" type="text" size="50"
value="Nutrition: New onset diabetes, BMI > 25
Hypertension: Maximize treatment and not to goal
Cardiology: Patient with decompensated CHF / hospitalized

"}<br>

<input type='hidden' name='force_new_version' value='true'>

<input type='hidden' name="external_id" value="{$user_id}" id="external_id">
{submit}
</form>
<!--END from /var/www/html/php4/ydp_trunk/local/templates/ydpprotocol/protocol_form_template.html comment made with MMCM-->